The First Application of Positron Emission Tomography/ Magnetic Resonance Imaging in Russia
https://doi.org/10.20862/0042-4676-2019-100-3-161-165
Abstract
PET/MRI is a new hybrid imaging technique that involves all achievements of modern magnetic resonance imaging (MRI) and positron emission tomography (PET). PET/MRI has advantages over other imaging methods and will most likely soon become the gold standard for visualization in some areas of radiodiagnosis. This clinical case demonstrates the first application of PET/MRI in Russia in a patient with multiple endocrine neoplasia type 1. PET/MRI has yielded more accurate data than PET/CT and SPECT/CT.
Keywords
positron emission tomography/magnetic resonance imaging,
positron emission tomography/computed tomography,
multiple endocrine neoplasia type 1
Supporting agencies: Not specified
About the Authors
A. S. Chaban
Center of Nuclear Medicine and Positron Emission Tomography, Central Clinical Hospital № 2 named after N.A. Semashko, Russian Railways
Russian Federation
Russian Federation
Artem S. Chaban - Radiologist, Center of Nuclear Medicine and Positron Emission Tomography, Central Clinical Hospital № 2 named after N.A. Semashko, Russian Railways.
ul. Budayskaya, 2, Moscow, 129128.
S. G. Mirzoyants
Center of Nuclear Medicine and Positron Emission Tomography, Central Clinical Hospital № 2 named after N.A. Semashko, Russian Railways
Russian Federation
Russian Federation
Sergey G. Mirzoyants - Cand. Med. Sc., Head of Center, Center of Nuclear Medicine and Positron Emission Tomography, Central Clinical Hospital № 2 named after N.A. Semashko, Russian Railways.
ul. Budayskaya, 2, Moscow, 129128.
M. R. Kalinin
Center of Nuclear Medicine and Positron Emission Tomography, Central Clinical Hospital № 2 named after N.A. Semashko, Russian Railways
Russian Federation
Russian Federation
Mikhail R. Kalinin - Dr. Med. Sc., Professor, Director of CCH № 2 n.a. N.A. Semashko, Center of Nuclear Medicine and Positron Emission Tomography, Central Clinical Hospital № 2 named after N.A. Semashko, Russian Railways.
ul. Budayskaya, 2, Moscow, 129128.
References
1. Rosenkrantz A.B., Friedman K., Chandarana H., Melsaether A., Moy L., Ding Y.S. et al. Current status of hybrid PET/MRI in oncologic imaging. Am. J. Roentgenol. 2016; 1 (206): 162–72.
2. Histed S.N., Lindenberg M.L., Mena E., Turkbey B., Choyke P.L., Kurdziel K.A. Review of functional/anatomical imaging in oncology. Nucl. Med. Communic. 2012; 4 (33): 349–61.
3. Ehman E.C., Johnson G.B., Villanueva-Meyer J.E., Cha S., Leynes A.P., Larson P.E.Z. Hope TA2. PET/MRI: where might it replace PET/CT? J. Magn. Reson. Imag. 2017; 5 (46): 1247–62.
4. Matos A.P., Velloni F., Ramalho M., Al Obaidy M., Rajapaksha A., Semelka R.C. Focal liver lesions: practical magnetic resonance imaging approach. World J. Hepatol. 2015; 16 (7): 1987–2008.
Review
For citations:
Chaban A.S., Mirzoyants S.G., Kalinin M.R. The First Application of Positron Emission Tomography/ Magnetic Resonance Imaging in Russia. Journal of radiology and nuclear medicine. 2019;100(3):161-165. (In Russ.) https://doi.org/10.20862/0042-4676-2019-100-3-161-165
Views:
2606
Email this article 